Nanjing Zhang

This inventor holds 21 USPTO granted patents and 15 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Ptc Therapeutics, Inc., F. Hoffmann-La Roche Ag, Fmc Corporation. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nanjing Zhang. Retrieved from https://idiyas.com/inventor/nanjing-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 15)

% Patents Active = 71.4

CIPO Patents = 2 (Patent Applications = 13)

EPO Patents = 10 (Patent Applications = 23)

Average Co-Inventor Count = 12.6

ph-index = 6

Forward Citations = 98(Granted Patents)

Company Filing History:

20 out of 186

Ptc Therapeutics, Inc.

patents

6 out of 181

F. Hoffmann-La Roche Ag

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Huntington's Disease

Spinal Muscular Atrophy

Antiviral Treatment

Heteroaryl Compounds

Pyrimidines

Indole Derivatives

Antibacterial Compounds

Hepatitis C

Thioeno Compounds

Familial Dysautonomia

Insecticidal Derivatives

Compounds for Treatment

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12577226 - Compounds for treating Huntington's disease (2026-03-17),

2. 12398140 - Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia (2025-08-26),

3. 12384797 - Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia (2025-08-12),

4. 12139499 - Heteroaryl compounds for treating Huntington's disease (2024-11-12),

5. 11858941 - Heterocyclic and heteroaryl compounds for treating Huntington's disease (2024-01-02),

6. 11780839 - Compounds for treating Huntington's disease (2023-10-10),

7. 11753407 - Compounds for treating spinal muscular atrophy (2023-09-12),

8. 11685746 - Heteroaryl compounds for treating Huntington's disease (2023-06-27),

9. 10851101 - Compounds for treating spinal muscular atrophy (2020-12-01),

10. RE47689 - Compounds for treating spinal muscular atrophy (2019-11-04),

11. 9879007 - Compounds for treating spinal muscular atrophy (2018-01-30),

12. 9650395 - Antibacterial compounds and methods for use (2017-05-16),

13. 9617268 - Compounds for treating spinal muscular atrophy (2017-04-11),

14. 9593108 - Compounds and methods for antiviral treatment (2017-03-14),

15. 9586955 - Compounds for treating spinal muscular atrophy (2017-03-07),

Title: Inventor Nanjing Zhang - Pioneering Innovations in Princeton

Introduction: Nanjing Zhang is a distinguished inventor based in Princeton, NJ, known for his groundbreaking contributions to various technological fields.

Latest Patents: Nanjing Zhang holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and ingenuity in the realm of innovation.

Career Highlights: With a career spanning over two decades, Nanjing Zhang has worked for leading tech companies, research institutions, and universities, where he has spearheaded numerous projects that have led to significant advancements in the industry.

Collaborations: Throughout his career, Nanjing Zhang has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge exchange that has been instrumental in his success.

Conclusion: Nanjing Zhang's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the field of inventing, with a legacy that continues to inspire future generations of inventors.

Profile summary based on public USPTO records.